Role of Ketogenic Diets in Multiple Sclerosis and Related Animal Models: An Updated Review

Thompson, 2018, Multiple sclerosis, Lancet, 391, 1622, 10.1016/S0140-6736(18)30481-1 Brenton, 2016, A study of dietary modification: perceptions and attitudes of patients with multiple sclerosis, Mult Scler Relat Disord, 8, 54, 10.1016/j.msard.2016.04.009 Brenton, 2019, Pilot study of a ketogenic diet in relapsing-remitting MS, Neurol Neuroimmunol Neuroinflamm, 6, e565, 10.1212/NXI.0000000000000565 Fitzgerald, 2018, A survey of dietary characteristics in a large population of people with multiple sclerosis, Mult Scler Relat Disord, 22, 12, 10.1016/j.msard.2018.02.019 Burgos, 2018, ESPEN guideline clinical nutrition in neurology, Clin Nutr, 37, 354, 10.1016/j.clnu.2017.09.003 Evans, 2019, An overview of the current state of evidence for the role of specific diets in multiple sclerosis, Mult Scler Relat Disord, 36, 101393, 10.1016/j.msard.2019.101393 Parks, 2020, Dietary interventions for multiple sclerosis-related outcomes, Cochrane Database Syst Rev, 5, CD004192 Bagur, 2017, Influence of diet in multiple sclerosis: a systematic review, Adv Nutr, 8, 463, 10.3945/an.116.014191 Augustin, 2018, Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders, Lancet Neurol, 17, 84, 10.1016/S1474-4422(17)30408-8 Koh, 2020, Ketogenic diet and neuroinflammation, Epilepsy Res, 167, 106454, 10.1016/j.eplepsyres.2020.106454 Offermanns, 2015, Nutritional or pharmacological activation of HCA(2) ameliorates neuroinflammation, Trends Mol Med, 21, 245, 10.1016/j.molmed.2015.02.002 Pinto, 2018, Anti-oxidant and anti-inflammatory activity of ketogenic diet: new perspectives for neuroprotection in Alzheimer's disease, Antioxidants (Basel), 7, 63, 10.3390/antiox7050063 Stafstrom, 2012, The ketogenic diet as a treatment paradigm for diverse neurological disorders, Front Pharmacol, 3, 59, 10.3389/fphar.2012.00059 Storoni, 2015, The therapeutic potential of the ketogenic diet in treating progressive multiple sclerosis, Mult Scler Int, 2015, 681289 Yuen, 2017, An acidosis-sparing ketogenic (ASK) diet to improve efficacy and reduce adverse effects in the treatment of refractory epilepsy, Epilepsy Behav, 74, 15, 10.1016/j.yebeh.2017.05.032 Olson, 2021, Alterations in the gut microbiota contribute to cognitive impairment induced by the ketogenic diet and hypoxia, Cell Host Microbe, 29, 10.1016/j.chom.2021.07.004 Choi, 2016, A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms, Cell Rep, 15, 2136, 10.1016/j.celrep.2016.05.009 Stumpf, 2019, Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease, Acta Neuropathol, 138, 147, 10.1007/s00401-019-01985-2 Kim, 2012, Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis, PLoS One, 7, e35476, 10.1371/journal.pone.0035476 Zhang, 2020, Amelioration of clinical course and demyelination in the cuprizone mouse model in relation to ketogenic diet, Food Funct, 11, 5647, 10.1039/C9FO02944C Lee, 2021, A modified MCT-based ketogenic diet increases plasma β-hydroxybutyrate but has less effect on fatigue and quality of life in people with multiple sclerosis compared to a modified paleolithic diet: a waitlist-controlled, randomized pilot study, J Am Coll Nutr, 40, 13, 10.1080/07315724.2020.1734988 Bock, 2018, Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis, EBioMedicine, 36, 293, 10.1016/j.ebiom.2018.08.057 Bock, 2022, Impact of dietary intervention on serum neurofilament light chain in multiple sclerosis, Neurol Neuroimmunol Neuroinflamm, 9, e1102, 10.1212/NXI.0000000000001102 Swidsinski, 2017, Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet, Front Microbiol, 8, 1141, 10.3389/fmicb.2017.01141 Nathan, 2019, Dietary therapy in secondary progressive multiple sclerosis: a case report, Cureus, 11, e5341 Kossoff, 2018, Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group, Epilepsia Open, 3, 175, 10.1002/epi4.12225 Benlloch, 2019, Satiating effect of a ketogenic diet and its impact on muscle improvement and oxidation state in multiple sclerosis patients, Nutrients, 11, 1156, 10.3390/nu11051156 Benlloch, 2019, Reply to “When is a ketogenic diet ketogenic? Comment on satiating effect of a ketogenic diet and its impact on muscle improvement and oxidation state in multiple sclerosis patients. Nutrients 2019, 11, 1156.”, Nutrients, 11, 1919, 10.3390/nu11081919 Cignarella, 2018, Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota, Cell Metab, 27, 10.1016/j.cmet.2018.05.006 Bahr, 2020, Ketogenic diet and fasting diet as nutritional approaches in multiple sclerosis (NAMS): protocol of a randomized controlled study, Trials, 21, 3, 10.1186/s13063-019-3928-9 Alexander, 2020, Deconstructing mechanisms of diet-microbiome-immune interactions, Immunity, 53, 264, 10.1016/j.immuni.2020.07.015 Tan, 2016, Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice, Proc Natl Acad Sci U S A, 113, E8141, 10.1073/pnas.1617460113 Schnell, 2021, Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity, Cell, 184, 10.1016/j.cell.2021.11.018 Ang, 2020, Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells, Cell, 181, 10.1016/j.cell.2020.04.027 Olson, 2018, The gut microbiota mediates the anti-seizure effects of the ketogenic diet, Cell, 173, 10.1016/j.cell.2018.04.027 Cox, 2021, Gut microbiome in progressive multiple sclerosis, Ann Neurol, 89, 1195, 10.1002/ana.26084 Seo, 2007, Efficacy and tolerability of the ketogenic diet according to lipid:nonlipid ratios—comparison of 3:1 with 4:1 diet, Epilepsia, 48, 801, 10.1111/j.1528-1167.2007.01025.x Masino, 2012, Mechanisms of ketogenic diet action, 1003 David, 2014, Diet rapidly and reproducibly alters the human gut microbiome, Nature, 505, 559, 10.1038/nature12820 Kipp, 2009, The cuprizone animal model: new insights into an old story, Acta Neuropathol, 118, 723, 10.1007/s00401-009-0591-3 Rangachari, 2013, Using EAE to better understand principles of immune function and autoimmune pathology, J Autoimmun, 45, 31, 10.1016/j.jaut.2013.06.008 Ransohoff, 2012, Animal models of multiple sclerosis: the good, the bad and the bottom line, Nat Neurosci, 15, 1074, 10.1038/nn.3168 Lin, 2020, Cognitive assessment and rehabilitation for pediatric-onset multiple sclerosis: a scoping review, Children (Basel), 7, 183 Liu, 2020, Cuprizone-induced demyelination in mouse hippocampus is alleviated by ketogenic diet, J Agric Food Chem, 68, 11215, 10.1021/acs.jafc.0c04604 Newman, 2017, β-Hydroxybutyrate: a signaling metabolite, Annu Rev Nutr, 37, 51, 10.1146/annurev-nutr-071816-064916 Nguyen, 2020, Dichotomous engagement of HDAC3 activity governs inflammatory responses, Nature, 584, 286, 10.1038/s41586-020-2576-2 Zhang, 2011, Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis, PLoS One, 6, e16795, 10.1371/journal.pone.0016795 Zhang, 2014, Expression of IL-33 and its epigenetic regulation in multiple sclerosis, Ann Clin Transl Neurol, 1, 307, 10.1002/acn3.47 Shimazu, 2013, Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor, Science, 339, 211, 10.1126/science.1227166 Göschl, 2018, A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis, J Autoimmun, 86, 51, 10.1016/j.jaut.2017.09.008 Martin, 2015, Role of SIRT1 in autoimmune demyelination and neurodegeneration, Immunol Res, 61, 187, 10.1007/s12026-014-8557-5 Tegla, 2014, SIRT1 is decreased during relapses in patients with multiple sclerosis, Exp Mol Pathol, 96, 139, 10.1016/j.yexmp.2013.12.010 Arun, 2013, Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride, Brain, 136, 106, 10.1093/brain/aws325 Friese, 2007, Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system, Nat Med, 13, 1483, 10.1038/nm1668 Zhu, 2019, Ketone bodies inhibit the opening of acid-sensing ion channels (ASICs) in rat hippocampal excitatory neurons in vitro, Front Neurol, 10, 155, 10.3389/fneur.2019.00155 Gökdoğan Edgünlü, 2020, The effect of FOXO gene family variants and global DNA methylation on RRMS disease, Gene, 726, 144172, 10.1016/j.gene.2019.144172 Zhang, 2020, Ketogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8(+) T-cell memory development, Nat Cell Biol, 22, 18, 10.1038/s41556-019-0440-0 Jablonska, 2012, Oligodendrocyte regeneration after neonatal hypoxia requires FOXO1-mediated p27Kip1 expression, J Neurosci, 32, 14775, 10.1523/JNEUROSCI.2060-12.2012 Palazuelos, 2014, TGFβ signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3/4/FoxO1/Sp1, J Neurosci, 34, 7917, 10.1523/JNEUROSCI.0363-14.2014 Kops, 2002, Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress, Nature, 419, 316, 10.1038/nature01036 Pfeiffer, 2019, Structural adaption of axons during de- and remyelination in the cuprizone mouse model, Brain Pathol, 29, 675, 10.1111/bpa.12748 Sevastou, 2016, Characterisation of transcriptional changes in the spinal cord of the progressive experimental autoimmune encephalomyelitis biozzi ABH mouse model by RNA sequencing, PLoS One, 11, e0157754, 10.1371/journal.pone.0157754 Hernandez, 2018, The antiepileptic ketogenic diet alters hippocampal transporter levels and reduces adiposity in aged rats, J Gerontol A Biol Sci Med Sci, 73, 450, 10.1093/gerona/glx193 Gautier, 2015, Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors, Nat Commun, 6, 8518, 10.1038/ncomms9518 Zheng, 2020, Proteomics for studying the effects of ketogenic diet against lithium chloride/pilocarpine induced epilepsy in rats, Front Neurosci, 14, 562853, 10.3389/fnins.2020.562853 Juge, 2010, Metabolic control of vesicular glutamate transport and release, Neuron, 68, 99, 10.1016/j.neuron.2010.09.002 Aryanpour, 2017, Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model, Int Immunopharmacol, 51, 131, 10.1016/j.intimp.2017.08.007 Hou, 2020, Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype, Cell Death Dis, 11, 377, 10.1038/s41419-020-2565-2 Schuh, 2015, Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations, Neurol Neuroimmunol Neuroinflamm, 2, e109, 10.1212/NXI.0000000000000109 Shippy, 2020, β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology, J Neuroinflammation, 17, 280, 10.1186/s12974-020-01948-5 Youm, 2015, The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease, Nat Med, 21, 263, 10.1038/nm.3804 Wouters, 2020, Altered PPARγ expression promotes myelin-induced foam cell formation in macrophages in multiple sclerosis, Int J Mol Sci, 21, 9329, 10.3390/ijms21239329 Zhang, 2017, Adiponectin suppresses T helper 17 cell differentiation and limits autoimmune CNS inflammation via the SIRT1/PPARγ/RORγt pathway, Mol Neurobiol, 54, 4908, 10.1007/s12035-016-0036-7 Duvanel, 2003, Inhibition of glial cell proinflammatory activities by peroxisome proliferator-activated receptor gamma agonist confers partial protection during antimyelin oligodendrocyte glycoprotein demyelination in vitro, J Neurosci Res, 71, 246, 10.1002/jnr.10471 Klotz, 2007, Brain endothelial PPAR-gamma controls inflammation-induced CD4+ T cell adhesion and transmigration in vitro, J Neuroimmunol, 190, 34, 10.1016/j.jneuroim.2007.07.017 Kanakasabai, 2012, PPARγ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes, PLoS One, 7, e50500, 10.1371/journal.pone.0050500 Hughes, 2014, The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells, J Neurochem, 129, 426, 10.1111/jnc.12646 Bove, 2019, Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients, Mult Scler, 25, 344, 10.1177/1352458517750768 Marrodan, 2021, Obesity and the risk of multiple sclerosis. The role of leptin, Ann Clin Transl Neurol, 8, 406, 10.1002/acn3.51291 Sanna, 2003, Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses, J Clin Invest, 111, 241, 10.1172/JCI200316721 Iwaki, 2003, Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors, Diabetes, 52, 1655, 10.2337/diabetes.52.7.1655 Banga, 2009, Adiponectin translation is increased by the PPARγ agonists pioglitazone and omega-3 fatty acids, Am J Physiol Endocrinol Metab, 296, E480, 10.1152/ajpendo.90892.2008 Rosenbaum, 2019, Glucose and lipid homeostasis and inflammation in humans following an isocaloric ketogenic diet, Obesity (Silver Spring), 27, 971, 10.1002/oby.22468 Partsalaki, 2012, Metabolic impact of a ketogenic diet compared to a hypocaloric diet in obese children and adolescents, J Pediatr Endocrinol Metab, 25, 697, 10.1515/jpem-2012-0131 Widiatmaja, 2021, The effect of long-term ketogenic diet on serum adiponectin and insulin-like growth factor-1 levels in mice, J Basic Clin Physiol Pharmacol